Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients

Pharmacotherapy
John A SegretiMichael S Finney

Abstract

To evaluate the outcomes in patients with bacteremia and/or infective endocarditis who were treated with daptomycin. Retrospective chart review. A university-affiliated medical center in Chicago, Illinois, and a regional hospital in Fountain Valley, California. Thirty-one inpatients treated with daptomycin for bacteremia and/or infective endocarditis. Patients were given daptomycin 4-6 mg/kg intravenously every 24-48 hours based on the practitioner's discretion and depending on the patient's clinical condition and presence of comorbidities. Primary end points were resolution of signs and symptoms of infection and discharge from the hospital. Methicillin-resistant Staphylococcus aureus ([MRSA] 11 patients) and vancomycin-resistant entercocci ([VRE] 11 patients) were the most common pathogens, whereas 7 patients had methicillin-sensitive S. aureus infection and 1 patient had coagulasenegative Staphylococcus infection. One patient with endocarditis had a negative culture result. Overall, 24 (77%) of the 31 patients achieved clinical resolution and were discharged, including all patients infected with MRSA; 7 patients died, 6 of whom had VRE infection. Duration of treatment for infective endocarditis lasted longer (typically 22-43 ...Continue Reading

References

Apr 7, 1999·The Journal of Infectious Diseases·V G FowlerL J Harrell
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M B EdmondR P Wenzel
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C GonzálezJ J Picazo
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·F B OlesonF P Tally
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Apr 9, 2004·Critical Care Medicine·Kevin B LauplandDeirdre L Church
Jul 1, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert D ArbeitUNKNOWN Daptomycin 98-01 and 99-01 Investigators

❮ Previous
Next ❯

Citations

Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·Donald P Levine
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·David M Livermore
Nov 19, 2008·The Journal of Antimicrobial Chemotherapy·Shellee A GrimNina M Clark
Apr 7, 2010·The Journal of Antimicrobial Chemotherapy·Rafael CantónAlan P Johnson
Jun 19, 2013·Antimicrobial Agents and Chemotherapy·Anthony M CasapaoMichael J Rybak
Feb 20, 2010·Annals of Clinical Microbiology and Antimicrobials·Marylene Duah
Feb 18, 2014·The Journal of Antimicrobial Chemotherapy·I CerónUNKNOWN Group for the Management of Infective Endocarditis of the Gregorio Marañón Hospital (GAME)
Sep 28, 2014·International Journal of Antimicrobial Agents·Jose M MunitaCesar A Arias
Oct 2, 2013·Antimicrobial Agents and Chemotherapy·Manuela CarugatiUNKNOWN International Collaboration on Endocarditis
May 15, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chien-Hsuan ChouWen-Chien Ko
Oct 12, 2007·Expert Opinion on Pharmacotherapy·Hisham Ziglam
Dec 14, 2011·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chung-Chih LaiShan-Chwen Chang
May 11, 2010·International Journal of Antimicrobial Agents·Anne-Marie ChaftariIssam Raad
Feb 10, 2009·International Journal of Antimicrobial Agents·John F MohrKenneth C Lamp
Aug 30, 2008·International Journal of Antimicrobial Agents·Paschalis I Vergidis, Matthew E Falagas
Jul 17, 2007·The Journal of Infection·David A EnochJ Andreas Karas
Jan 9, 2007·The Journal of Infection·Don HayesRobert J Kuhn
Aug 12, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Pavani ReddyGary A Noskin
Oct 16, 2007·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Ian Jenkins
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G PatelUNKNOWN AST Infectious Diseases Community of Practice
Oct 16, 2007·The American Journal of Medicine·George SakoulasRene Russo
Oct 16, 2007·The American Journal of Medicine·Donald P Levine, Kenneth C Lamp
Jun 21, 2011·Diagnostic Microbiology and Infectious Disease·Yehuda CarmeliMitchell J Schwaber
Apr 14, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Alison S VanEperen, John Segreti
May 21, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kimberly G BlumenthalRochelle P Walensky
Nov 2, 2006·Current Medical Research and Opinion·Javier Garau
Jun 30, 2015·Future Microbiology·J M PericásJ M Miró
Feb 2, 2013·European Journal of Internal Medicine·Karolina AkinosoglouGeoffrey Pasvol
Jan 10, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Selçuk KayaIftihar Köksal
Sep 24, 2014·The Journal of Antimicrobial Chemotherapy·Jolanta PiszczekEric Partlow
Feb 12, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Y Aksoy, S Unal
Dec 16, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G Sakoulas
Jul 27, 2007·The Annals of Pharmacotherapy·Kari A Mergenhagen, Mary T Pasko
Mar 4, 2010·The Annals of Pharmacotherapy·Jeffrey S StroupTerry Badzinski

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

The New England Journal of Medicine
Vance G FowlerS. aureus Endocarditis and Bacteremia Study Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert D ArbeitDaptomycin 98-01 and 99-01 Investigators
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Christopher F Carpenter, Henry F Chambers
© 2021 Meta ULC. All rights reserved